8-K/A
Current Report
Taysha Gene Therapies, Inc. Filed Acc 0001193125-23-064669
Executive or director change
- Item 5.02 Departure or appointment of directors or officers
From the SEC's structured data for this filing
Loading d464178d8ka.htm…